FT Options »

Teva Pharmaceutical Industries shares owned by FT Options

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by FT Options from 13F filings

Historical chart of FT Options investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by FT Options consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by FT Options

Quarter filed Position value Share count Share price at filing
2017-09-30 $171k 380k 0.45
2016-12-31 $263k 7.3k 36.28
2016-09-30 $4.2M 92k 46.01

More positions owned by FT Options

Incyte Corporation (INCY)
Gilead Sciences (GILD)
Clovis Oncology
iShares NASDAQ Biotechnology Index (IBB)
Insmed (INSM)
Gw Pharmaceuticals Plc ads
Tesaro
Time Warner
Abbvie (ABBV)
General Mills (GIS)
Regeneron Pharmaceuticals (REGN)
Dbv Technologies S A (DBVT)
Kimberly-Clark Corporation (KMB)
Zogenix
Clorox Company (CLX)

View all positions for FT Options

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Susquehanna International
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Arrowstreet Capital, Limited Partnership

View all funds holding Teva Pharmaceutical Industries